AgingResearch.NewsJoin free

Endovascular Engineering

CompanyUnited States

Endovascular Engineering develops 2 assets, the furthest approved (Hēlo Return in pulmonary embolism). Mostly device; based in the United States.

2
Assets
Furthest stage
Approved
0
Trials
0
Signals

Pipeline

2

  • Hēlo Return

    Returns blood during aspiration thrombectomy.

    Approved, Device, pulmonary embolism

  • Hēlo Thrombectomy System

    Removes blood clots using vacuum aspiration.

    Approved, Device, pulmonary embolism

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Similar companies2

Intelligence